首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.
【2h】

Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.

机译:移植和艾滋病患者血液白细胞和血浆中人巨细胞病毒DNA的定量比较。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A new method for the quantitation of human cytomegalovirus (HCMV) DNA was used to determine the levels of viral DNA in parallel in 120 blood leukocyte (leukoDNAemia) and plasma (plasmaDNAemia) samples from 8 heart or heart-lung transplant patients and 17 AIDS patients with disseminated HCMV infection. PlasmaDNAemia was consistently associated with leukoDNAemia in both groups of patients. However, at least in the transplant patients, plasmaDNAemia was not necessarily associated with clinical symptoms, appearing later and disappearing earlier than leukoDNAemia during the course of infection. Quantitative mean levels of leukoDNAemia were mostly higher than those of plasmaDNAemia in both transplant and AIDS patients. However, in the absence of antiviral treatment, plasmaDNAemia levels were significantly higher in AIDS patients than in transplant recipients, whereas leukoDNAemia levels were not significantly different between the two groups of patients. A significant correlation was found between leukoDNAemia and plasmaDNAemia in AIDS patients, as well as in transplant recipients, although to a lesser degree. However, from a diagnostic standpoint, quantitative determination of plasmaDNAemia appears to represent a much less sensitive parameter than that of leukoDNAemia (or antigenemia) for monitoring HCMV infections and antiviral treatment.
机译:一种新的定量人类巨细胞病毒(HCMV)DNA的方法被用于确定8例心脏或心肺移植患者和17例AIDS患者的120份血液白细胞(leukoDNAemia)和血浆(plasmaDNAemia)样品中病毒DNA的平行水平传播HCMV感染。在两组患者中血浆DNA血症与白细胞DNA血症始终相关。但是,至少在移植患者中,血浆DNA血症不一定与临床症状相关,在感染过程中,血浆DNA血症比白细胞DNAemia出现得更晚,消失得更早。在移植和艾滋病患者中,白细胞DNA的定量平均水平大多高于血浆DNA的平均水平。但是,在没有抗病毒治疗的情况下,艾滋病患者的血浆DNA血药水平明显高于移植接受者,而两组患者的白细胞DNA血药水平无显着差异。在艾滋病患者以及移植受者中,白细胞DNA血和血浆DNA血之间存在显着相关性,尽管程度较小。但是,从诊断的角度看,血浆DNA血症的定量测定似乎比用于监测HCMV感染和抗病毒治疗的白细胞DNA血症(或抗原血症)的敏感性参数低得多。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号